Results 51 to 60 of about 12,580 (199)

Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation

Biopharmaceutics &Drug Disposition, EarlyView.
Pharmacokinetic interactions between Echinacea and two antiviral drugs, favipiravir and atazanavir, were assessed in rats. The findings suggest that Echinacea does not significantly affect the pharmacokinetics of favipiravir and atazanavir. These results provide preliminary evidence that concurrent use of Echinacea with these antiviral drugs may be ...
Siva Nageswara Rao Gajula, Jeevan Sai Kallam, Aarika Kanukolanu, Ganesh Korada, Lakshmi Vineela Nalla   +4 more
wiley   +1 more source

Çok Tartışılan Bir İlacın Hikayesi; Favipiravir

, 2023
ÖZETAmaç: Koronavirüs hastalığı (Covid-19) pandemisinde favipiravir Sağlık Bakanlığı tarafından tedavi amacıyla ücretsiz olarak dağıtılmıştır. Bu çalışmanın amacı, hastaların favipiraviri kullanma durumları ve buna etki eden faktörlerin araştırılmasıdır ...
Mıstanoğlu Özatağ, Duru, Duru MISTANOĞLU ÖZATAĞ, Durmaz, Adem, Adem DURMAZ   +3 more
core   +1 more source

Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial

Frontiers in Pharmacology, 2021
Background: In addition to supportive therapy, antiviral therapy is an effective treatment for coronavirus disease 2019 (COVID-19).Objective: To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19 patients.Methods ...
Chang Chen, Chang Chen, Yi Zhang, Yi Zhang, Jianying Huang, Jianying Huang, Ping Yin, Zhenshun Cheng, Jianyuan Wu, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Bo Chen, Mengxin Lu, Yongwen Luo, Lingao Ju, Jingyi Zhang, Xinghuan Wang, Xinghuan Wang, Xinghuan Wang, Xinghuan Wang   +21 more
doaj   +1 more source

Membrane‐Permeable Nucleoside T‐1106 Diphosphate and Triphosphate Analogues as Antiviral Pronucleotides

Chemistry – A European Journal, EarlyView.
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier, Duan Li, Leentje Persoons, Graciela Andrei, Robert Snoeck, Dominique Schols, Lieve Naesens, Xiao Jia   +7 more
wiley   +1 more source

Obstructive sleep apnea and major depressive disorder: Shared transcriptional signatures and candidate pathways identified via bioinformatics analysis

Sleep Research, EarlyView.
Abstract Background Obstructive sleep apnea (OSA) frequently co‐occurs with major depressive disorder (MDD). However, the underlying biological mechanisms remain unclear. This study aimed to identify OSA‐related transcriptional signatures associated with depressive status using integrated bioinformatics and machine learning.
Yun‐Shu Sun, Fei Wang, Qian‐Ting Zhong, Shi‐Bin Wang, Fu‐Jun Jia, Cai‐Lan Hou   +5 more
wiley   +1 more source

Pengaruh Penggunaan Favipiravir terhadap Gejala Klinis Pasien Rawat Inap COVID-19 di RSU Santa Elisabeth Purwokerto [PDF]

, 2022
Coronavirus Disease 2019 (COVID-19) adalah penyakit yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Salah satu terapi yang digunakan untuk COVID-19 yaitu antivirus favipiravir.
ASTUTI, Wiwi
core  

Favipiravir [PDF]

Reactions Weekly, 2021
  +6 more sources

Analytical Green Star Area for Sample Preparation (AGSA‐Prep) as a Comprehensive and Practice‐Oriented Metric

Analytical Science Advances, Volume 7, Issue 1, June 2026.
ABSTRACT Sample preparation is a critical, yet often environmentally burdensome, step in analytical chemistry. While Green Sample Preparation principles aim to mitigate this impact, existing assessment tools such as AGREEprep offer room for improvement in the assessment process.
Fotouh R. Mansour, Reem H. Obaydo, Marcello Locatelli, Alaa Bedair   +3 more
wiley   +1 more source

Effectiveness of Early Favipiravir Therapy in Hospitalised COVID-19 Patients

, 2022
COVID-19 is a disease caused by a novel coronavirus with no specific, standard treatment. We investigated the clinical data of COVID-19 patients admitted to King Fahad Specialist Hospital (KFSH) in Buraydah by comparing the patients who were treated ...
Abdulrahman Alzahrani, Arwa Alzahrani, Mohammed Ali Alshehri, Mohammed S. Aldughaim, Alothaid, Hani, Almitairi, Jamal, Alzahrani, Abdulrahman, Jamal Almitairi, Abdulrahman Tawfik, Alzahrani, Arwa, Hani Alothaid, Tawfik, Abdulrahman, Sami Alharbi, Aldughaim, Mohammed S., Alharbi, Sami, Alshehri, Mohammed Ali   +15 more
core   +1 more source

Determination of favipiravir IC50 value.

, 2022
293T cells were infected with Candid #1 (MOI: 0.1). After adsorption, media containing serial dilutions of favipiravir was added. At 48 hpi, supernatant was collected, and viral titers were determined by plaque assay.
Jiro Yasuda (32563), Haruka Abe (3174081), Tosin Oladipo Afowowe (13029128), Shuzo Urata (32561), Vahid Rajabali Zadeh (13029125)   +4 more
core   +1 more source